Interview with Janusz Obukowicz, Managing Director, Pharmaceutical Reearch…
Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for…
Address: ul. Zbąszyńska 3 91-342 Łódź
,Poland
Tel: +48 (42) 61 33 444
Web: http://www.pelion.eu/s/60
PGF is the leading company working in healthcare business, concentrating on drug and medical products supply. It derives from 1990 when Mr. Jacek Szwajcowski established the pharmaceutical wholesale – MEDICINES. It was designed to help to transform polish pharma-services into a modern, efficient and quality-driven system.
When wholesale trade in pharmaceuticals was deregulated, it became clear that top market standards could only be achieved by a large organisation with nationwide coverage. Thanks to a series of mergers and acquisitions, PGF has become such a company.
As the most popular domestic wholesale distributor of pharmaceuticals, we have optimised our nationwide sales network. We offer 18 thousand different types of pharmaceutical items from every single existing pharmacological group. We don’t just stop at pharmaceuticals. We sell medical equipment, herbal preparations, and cosmetics. Pharmaceutical sales is PGF’s main revenue (more than 90%), and its share is growing continually. At present, our objective is to harness the opportunities emerging in the ever expanding pharmaceuticals market in Poland.
PGF, the decision making headquarters, manages contact with drug makers and distribution within the PGF group through two branches, in Łódź and Katowice. Thanks to our centralised procurement and given the scale of the Group’s operations, we have been able to secure advantageous supply agreements, which in turn enables us to offer the most attractive service to our customers.
The pharmaceutical distribution is carried out by our subsidiary companies located throughout the whole country. This helps us to maintain a strong position on all the local markets.
PGF also distributes pharmaceuticals to hospitals. Our excellent range on offer and efficient customer service has made us the unquestionable market leader in this segment, supplying one in every three pharmaceutical items used for in-patient health care.
PGF’s strong market position is beneficial to smaller companies also active in pharmaceutical distribution. With annual revenues of more than bilion, PGF as the largest private company established in post-communism Poland ranks among the 100 biggest Central&Eastern Europe companys.
The strategic objective of the Group is to become the leader in Central and Eastern Europe, by consolidating the retail markets in countries of the region. The Group operates in the healthcare sector in Poland and Lithuania. Its services cover all market segments (wholesale, retail sale and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers.
Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for…
You became president of the board at Medicover in Poland only a while ago and previously your previous experience was in high-profile management but not in healthcare. Do you now…
IMS ‘lives and breathes the pharma industry’ and it is stimulating to come from other forms of consultancy to IMS. You have worked in various businesses. What motivated you to…
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
As we are just entering 2011, could you share with us the results of the Polish affiliate in 2010? 2010 was for Ferring Poland a year of reconstruction. The affiliate…
Adamed was founded in 1986 by your father, Mr. Marian Adamkiewicz. The company is today still fully-owned by your family, which is remarkable in such an industry, where family-run businesses…
You joined Merck in September 1996, took gradually increasing positions at Merck, from Medical Representative (1996 – 1998), to Sales and Marketing managing positions and you were ultimately appointed Managing…
You have been appointed at the head of Pfizer Poland last December. 2010 is a hot year for the group – even very hot for some of the top management…
Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was telling us that the main opportunity of the Polish market lies…
What is PharmaExpert’s role in the Polish pharmaceutical industry? The information that PharmaExpert gathers enables us to give good insight about the evolution of the pharmacists market, the evolution of…
See our Cookie Privacy Policy Here